Does TAFASITAMAB-CXIX Cause Diffuse large b-cell lymphoma? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Diffuse large b-cell lymphoma have been filed in association with TAFASITAMAB-CXIX. This represents 4.4% of all adverse event reports for TAFASITAMAB-CXIX.
32
Reports of Diffuse large b-cell lymphoma with TAFASITAMAB-CXIX
4.4%
of all TAFASITAMAB-CXIX reports
13
Deaths
4
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From TAFASITAMAB-CXIX?
Of the 32 reports, 13 (40.6%) resulted in death, 4 (12.5%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Disease progression (218)
Lymphoma (158)
Off label use (126)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Malignant neoplasm progression (30)
Neutropenia (30)
Polyneuropathy (29)
Covid-19 (28)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which TAFASITAMAB-CXIX Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB